Antiangiogenic agents plus chemotherapy

Date 17 December 2016
Event ESMO Asia 2016 Congress
Session Therapy for advanced lung cancer beyond EGFR TKI and ALK inhibitors
Presenter Edward Garon
Authors E. Garon
  • David Geffen School of Medicine at UCLA, Santa Monica, CA/US